Your new experience awaits. Try the new design now and help us make it even better

CASE REPORT article

Front. Med.

Sec. Obstetrics and Gynecology

Volume 12 - 2025 | doi: 10.3389/fmed.2025.1584099

This article is part of the Research TopicAdvancements in Diagnostic and Management Strategies for Gynecological PathologiesView all 22 articles

Medical Treatment of Acquired Uterine Arteriovenous Fistulae Related to Pregnancy: 2 Cases and literature review

Provisionally accepted
Lingna  HuangLingna Huang1Lini  QiuLini Qiu1Jinwen  ZhangJinwen Zhang2Hui  YeHui Ye1Xiumei  XiongXiumei Xiong1*
  • 1Fujian Maternity and Child Health Hospital, Fuzhou, China
  • 2Fujian Medical University, Fuzhou, Fujian Province, China

The final, formatted version of the article will be published soon.

Uterine arteriovenous fistula (UAVF) is a rare form of uterine arteriovenous malformation, the most characteristic clinical symptom of which is intermittent vaginal bleeding. Currently, reports on the treatment of UAVF mainly focus on uterine artery embolization (UAE), high-intensity focused ultrasound (HIFU), and surgical treatment, with relatively few reports on medical conservative therapy. This article reports the process and outcomes of medical treatment for two cases of pregnancy-related acquired UAVF and summarizes and analyzes the indications and drug selection for UAVF medical conservative treatment on the basis of the relevant literature.

Keywords: uterine arteriovenous fistula, Pregnancy-related, Medical treatment, PSV = peak systolic velocity, Progesterone, GnRH-a

Received: 26 Feb 2025; Accepted: 14 Jul 2025.

Copyright: © 2025 Huang, Qiu, Zhang, Ye and Xiong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Xiumei Xiong, Fujian Maternity and Child Health Hospital, Fuzhou, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.